Correlation Between Edgewise Therapeutics and Allakos
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Allakos at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Allakos into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Allakos, you can compare the effects of market volatilities on Edgewise Therapeutics and Allakos and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Allakos. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Allakos.
Diversification Opportunities for Edgewise Therapeutics and Allakos
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Edgewise and Allakos is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Allakos in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allakos and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Allakos. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allakos has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Allakos go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Allakos
Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 0.78 times more return on investment than Allakos. However, Edgewise Therapeutics is 1.28 times less risky than Allakos. It trades about 0.08 of its potential returns per unit of risk. Allakos is currently generating about -0.02 per unit of risk. If you would invest 798.00 in Edgewise Therapeutics on September 3, 2024 and sell it today you would earn a total of 2,502 from holding Edgewise Therapeutics or generate 313.53% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Edgewise Therapeutics vs. Allakos
Performance |
| Timeline |
| Edgewise Therapeutics |
| Allakos |
Edgewise Therapeutics and Allakos Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and Allakos
The main advantage of trading using opposite Edgewise Therapeutics and Allakos positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Allakos can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allakos will offset losses from the drop in Allakos' long position.| Edgewise Therapeutics vs. DiaMedica Therapeutics | Edgewise Therapeutics vs. Lyra Therapeutics | Edgewise Therapeutics vs. Centessa Pharmaceuticals PLC |
| Allakos vs. Apellis Pharmaceuticals | Allakos vs. Blueprint Medicines Corp | Allakos vs. Day One Biopharmaceuticals | Allakos vs. Atara Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |